基本信息
views: 194
Career Trajectory
Bio
Further, he has established a managed clinical network for ovarian cancer for all hospitals in the North-East of the Netherlands (catchment area 3.5 million people) to improve the care for ovarian cancer patients and which forms a unique platform for translational research.
Professor Van der Zee is past President of the European Society for Gynecologic Oncology (2009 – 2011) and past president of the Dutch Working Party for Gynecologic Oncology. He serves and has served on various national and international advisory and program committees / Boards, including Dutch Cancer Society, NCRN UK, NCI USA, IGCS, ESGO, DHD, CGS and the General Board of the Capacity Body of behalf of the Dutch Federation of University Medical Centers.From 2014 - 2019 he was chairman of the Netherlands Federation of UMCs (NFU)-consortium Quality of Care, in which all Dutch UMCs collaborate on improving patient outcomes.
Prof. Van der Zee has also created a long and productive translational research line on prognostic and predictive factors in gynecologic cancer. He is leading a world-wide consortium (GROINSS-V-II) together with Dr. Oonk, which performs landmark clinical studies in vulvar cancer. He co-authored > 270 peer-reviewed publications. Under his guidance 40 PhD theses were completed. Since January 2013, he joined the Board of Directors of the University Medical Center Groningen.
He combines his currect chairman position with clinical research, performing surgery in Gynaecological Oncology, seeing patients during consulting hours, academic research and mentoring PhD students.
Professor Van der Zee is past President of the European Society for Gynecologic Oncology (2009 – 2011) and past president of the Dutch Working Party for Gynecologic Oncology. He serves and has served on various national and international advisory and program committees / Boards, including Dutch Cancer Society, NCRN UK, NCI USA, IGCS, ESGO, DHD, CGS and the General Board of the Capacity Body of behalf of the Dutch Federation of University Medical Centers.From 2014 - 2019 he was chairman of the Netherlands Federation of UMCs (NFU)-consortium Quality of Care, in which all Dutch UMCs collaborate on improving patient outcomes.
Prof. Van der Zee has also created a long and productive translational research line on prognostic and predictive factors in gynecologic cancer. He is leading a world-wide consortium (GROINSS-V-II) together with Dr. Oonk, which performs landmark clinical studies in vulvar cancer. He co-authored > 270 peer-reviewed publications. Under his guidance 40 PhD theses were completed. Since January 2013, he joined the Board of Directors of the University Medical Center Groningen.
He combines his currect chairman position with clinical research, performing surgery in Gynaecological Oncology, seeing patients during consulting hours, academic research and mentoring PhD students.
Research Interests
Papers共 521 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of the National Comprehensive Cancer Network : JNCCNno. 2 (2024)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
DERMATOLOGYno. 3 (2023): 362-367
crossref(2023)
Load More
Author Statistics
#Papers: 527
#Citation: 28277
H-Index: 83
G-Index: 150
Sociability: 8
Diversity: 1
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn